Nootropics Index - Save on smarter supplements
Vitamins & vitamin-like compounds

Benfotiamine

Benfotiamine (lipid-soluble thiamin derivative)

Benfotiamine is a synthetic lipid-soluble thiamin derivative, not an ordinary B1 salt; for a useful product comparison, look for the exact benfotiamine amount, trial-relevant context, adverse-event reporting, and independent identity testing.

Clinical ResearchLimited Human EvidenceLong Term Safety Unknown
Updated August 2026/4 min read/2 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

Identity and form

1

Benfotiamine is a synthetic lipid-soluble thiamin derivative, not an ordinary B1 salt.

02

Mechanisms of action

Biological role

1

It is designed to raise thiamin-related metabolites, but biochemical exposure does not by itself establish a cognitive benefit.

03

Potential effects and evidence map

Human evidence is limited and form-specific. Biochemical plausibility or disease-population studies do not establish a general focus, memory, energy, or healthy-aging benefit for healthy users.

Effect domainMagnitudeGrade
Mental energy / wakefulness1
UnknownConfidence: Medium

Evidence does not establish a reliable mental-energy effect from extra Benfotiamine in well-nourished healthy adults.

Note Essential nutrient biology and correction of inadequate status are different from enhancement.

0/5
C
Memory / learning1
UnknownConfidence: Medium

Direct evidence does not establish a general memory or learning benefit from Benfotiamine for healthy adults.

Note Keep form- and population-specific clinical research separate.

0/5
C
04

Timing & effect horizon

Effect horizonUnknown
Unknown
What timing evidence can show1

No reliable acute nootropic onset, duration, The time for blood levels to fall by half during the final elimination phase.Source claim, or routine cycle is established for Benfotiamine. Nutrient-status correction and clinical follow-up periods answer different questions.

05

Safety, side effects and risk profile

Evidence uncertainty1
Confidence: High

Marketing claims extend beyond the established nutrient or precursor evidence.

Note Separate adequacy, biochemical activity, and enhancement outcomes.

2/5
B
Interaction risk2
Confidence: Low

Medication-interaction evidence for benfotiamine is limited.

Note Do not infer compatibility from short pharmacokinetic and tolerability studies.

1/5
D
Dose- and form-specific safety2

Short phase I studies in healthy adults found generally acceptable tolerability across tested single and repeated doses, but they do not establish long-term safety, pregnancy or lactation safety, or a routine nootropic dose.

06

Interactions and cautions

Medication and test context1

Medication-interaction data are limited; it is not interchangeable with nutritional thiamin guidance.

07

Practical buying and quality notes

  • Look for the exact benfotiamine amount, trial-relevant context, adverse-event reporting, and independent identity testing.1
08

FAQ

What distinguishes Benfotiamine from related forms?

2

Benfotiamine is a synthetic thiamin derivative rather than an ordinary nutritional salt. The cited short phase I studies assessed pharmacokinetics and tolerability; they did not establish a healthy-user nootropic benefit.

09

References

  1. NIH Office of Dietary Supplements. Thiamin Fact Sheet for Health Professionals.
  2. Sheng L et al. Safety, tolerability and pharmacokinetics of single and multiple ascending doses of benfotiamine in healthy subjects. 2021.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.